PT Millennium Pharmacon International Tbk (ISX:SDPC) PS Ratio: 0.06 (As of Aug. 01, 2026) — 20% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:SDPC PT Millennium Pharmacon International Tbk ISX:SDPC
79 GF Score
Price Rp181.00
GF Value Rp166.83
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is PT Millennium Pharmacon International Tbk PS Ratio?

PT Millennium Pharmacon International Tbk ISX:SDPC 79 PS Ratio is 0.06 as of Aug. 01, 2026, which is 20% above its 10-year median of 0.05. GuruFocus rates ISX:SDPC with a GF Score™ of 79/100 and a GF Value™ of Rp166.83 (Fairly Valued). The stock has 5 warning signs investors should review. Among 119 Medical Distribution companies, PT Millennium Pharmacon International Tbk ranks better than 97.48% on this metric.

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, PT Millennium Pharmacon International Tbk's share price is Rp181.00. PT Millennium Pharmacon International Tbk's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was Rp3,255.57. Hence, PT Millennium Pharmacon International Tbk's PS Ratio for today is 0.06.

Warning Sign:

PT Millennium Pharmacon International Tbk stock PS Ratio (=0.06) is close to 2-year high of 0.06.

The historical rank and industry rank for PT Millennium Pharmacon International Tbk's PS Ratio or its related term are showing as below:

ISX:SDPC' s PS Ratio Range Over the Past 10 Years
Min: 0.03   Med: 0.05   Max: 0.14
Current: 0.06

During the past 13 years, PT Millennium Pharmacon International Tbk's highest PS Ratio was 0.14. The lowest was 0.03. And the median was 0.05.

ISX:SDPC's PS Ratio is ranked better than
97.48% of 119 companies
in the Medical Distribution industry
Industry Median: 0.4 vs ISX:SDPC: 0.06

PT Millennium Pharmacon International Tbk's Revenue per Sharefor the three months ended in Mar. 2026 was Rp799.04. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was Rp3,255.57.

During the past 12 months, the average Revenue per Share Growth Rate of PT Millennium Pharmacon International Tbk was 5.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was 8.70% per year. During the past 5 years, the average Revenue per Share Growth Rate was 9.20% per year. During the past 10 years, the average Revenue per Share Growth Rate was 2.60% per year.

During the past 13 years, PT Millennium Pharmacon International Tbk's highest 3-Year average Revenue per Share Growth Rate was 16.10% per year. The lowest was -9.60% per year. And the median was 8.55% per year.

Back to Basics: PS Ratio


PT Millennium Pharmacon International Tbk  (ISX:SDPC) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


PT Millennium Pharmacon International Tbk PS Ratio Related Terms


PT Millennium Pharmacon International Tbk PS Ratio Historical Data

* Premium members only.

The historical data trend for PT Millennium Pharmacon International Tbk's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Millennium Pharmacon International Tbk PS Ratio Chart

PT Millennium Pharmacon International Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.06 0.13 0.06 0.04 0.05

PT Millennium Pharmacon International Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.04 0.04 0.05 0.06

ISX:SDPC vs MCK, COR, CAH: PS Ratio Comparison

For the Medical Distribution subindustry, PT Millennium Pharmacon International Tbk's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Millennium Pharmacon International Tbk PS Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, PT Millennium Pharmacon International Tbk's PS Ratio distribution charts can be found below:

* The bar in red indicates where PT Millennium Pharmacon International Tbk's PS Ratio falls into.


ISX:SDPC
79GF Score
PT Millennium Pharmacon International Tbk ISX:SDPC
PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Millennium Pharmacon International Tbk PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

PT Millennium Pharmacon International Tbk's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=181.00/3255.571
=0.06

PT Millennium Pharmacon International Tbk's Share Price of today is Rp181.00.
PT Millennium Pharmacon International Tbk's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp3,255.57.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.

Frequently Asked Questions Learn more about PS Ratio →
What does a PS Ratio of 0.06 mean?
PT Millennium Pharmacon International Tbk (ISX:SDPC) has a PS Ratio of 0.06 as of Aug. 01, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on PT Millennium Pharmacon International Tbk and its competitors. This is 20% above median its historical median of 0.05. Over the past decade, PT Millennium Pharmacon International Tbk's PS Ratio has ranged from 0.03 to 0.14. According to the industry distribution chart, PT Millennium Pharmacon International Tbk ranks #3 out of 119 companies in the Medical Distribution industry, placing it in the top 2.5%.
Is PT Millennium Pharmacon International Tbk's PS Ratio too high?
PT Millennium Pharmacon International Tbk's current PS Ratio of 0.06 is 20% above median its 10-year median of 0.05. Over the past 10 years, this metric has ranged from a low of 0.03 to a high of 0.14. The Medical Distribution industry median PS Ratio is 0.40. PT Millennium Pharmacon International Tbk's value of 0.06 is 85% below this industry median. Based on the distribution chart, PT Millennium Pharmacon International Tbk ranks #3 out of 119 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, PT Millennium Pharmacon International Tbk has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PT Millennium Pharmacon International Tbk's PS Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, PT Millennium Pharmacon International Tbk ranks #3 out of 119 companies for PS Ratio. This places PT Millennium Pharmacon International Tbk in the top 3% of its industry — outperforming the majority of peers. The industry median PS Ratio is 0.40. PT Millennium Pharmacon International Tbk's value of 0.06 is 85% below this benchmark. Historically, PT Millennium Pharmacon International Tbk's own PS Ratio has ranged from 0.03 to 0.14 over the past decade. While the company's 10-year median is 0.05 vs. the industry median of 0.40, PT Millennium Pharmacon International Tbk has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Distribution company?
The median PS Ratio among Medical Distribution companies is 0.40, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Millennium Pharmacon International Tbk's current PS Ratio of 0.06 is 85% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on PT Millennium Pharmacon International Tbk and its competitors. For the Medical Distribution industry, the median PS Ratio is 0.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Millennium Pharmacon International Tbk's current PS Ratio is 0.06, which is 20% above median its own 10-year median of 0.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Millennium Pharmacon International Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Millennium Pharmacon International Tbk (ISX:SDPC) is currently considered Fairly Valued. The stock's GF Value™ is Rp166.83, compared to a current price of Rp181.00 — trading 8.5% above its estimated fair value. The current PS Ratio is 0.06, which is 20% above median its 10-year median of 0.05 and 85% below the Medical Distribution industry median of 0.40. PT Millennium Pharmacon International Tbk's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For PT Millennium Pharmacon International Tbk (ISX:SDPC), the current PS Ratio is 0.06 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Millennium Pharmacon International Tbk (ISX:SDPC) Overvalued in 2026?

Based on GuruFocus' analysis, PT Millennium Pharmacon International Tbk stock appears to be overvalued. The current stock price of Rp181.00 is trading 8.5% above its estimated GF Value™ of Rp166.83. GuruFocus considers PT Millennium Pharmacon International Tbk to be Fairly Valued.

Key valuation signals for ISX:SDPC:

  • PS Ratio: 0.06 (20% above median its 10-year median of 0.05)
  • GF Value™: Rp166.83 vs. price of Rp181.00 (8.5% above fair value)
  • GF Score™: 79/100 with 5 warning signs
  • Industry Position: 85% below the Medical Distribution median (#3 of 119)

No single metric tells the full story. See the ISX:SDPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Millennium Pharmacon International Tbk Business Description

Address Jl. Sultan Iskandar Muda No 18/Jl. Bungur No. 1, Crown Bungur Arteri Lantai 2-4, Kel. Kebayoran Lama Selatan, Kec. Kebayoran Lama, South Jakarta, Jakarta, IDN, 12240
PT Millennium Pharmacon International Tbk is engaged in distributing medicines, food supplements, and medical disposables. The group's operating segments are Prescription medicine, Non-prescription medicine, Medical Disposables, and others, of which the majority of revenue is derived from the Prescription Medicine segment. The company's geographical segments are Jawa, Sumatra, Kalimantan, Sulawesi, and Bali & Lombok.
79GF Score

Get the complete analysis for ISX:SDPC

PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp181.00
Price
Rp166.83
GF Value